Skip to content
★ Sign in to follow
LJ
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€674k
▼ Sales (0 ops.)
—

Latest filing published 18 Mar 2016 for Capricor Therapeutics, INC., €154k.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7
Positive at T+90
75%
Median T+90
+31.8%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Louis J. Grasmick: trading record in brief

Louis J. Grasmick discloses dealings in Capricor Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 21 January 2015 to 16 March 2016, the count stands at 7 filings.

The open-market record is one-sided, with 7 purchases worth €674k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2016: 2 purchases and no sales on the market.

A typical purchase (the median) is worth €17k. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +31.8%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 18 March 2016, the filings show an open-market purchase worth €44k in Capricor Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Louis J. Grasmick

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total

5 of 5 declarations